England to ban single-use e-cigarettes from June 2025

Oct.24.2024
England to ban single-use e-cigarettes from June 2025
The UK government has announced that England will ban the sale of single-use e-cigarettes from 1 June 2025. On the 22nd of this month, the Welsh Government also issued a statement on its official website confirming a ban on the use of disposable e-cigarettes from June 2025. Currently, two of the four UK regions have issued official statements on the matter.

The UK government announced on its official website on 24th October that England will ban the sale of single-use e-cigarettes from 1 June 2025.

 

Minister for the Circular Economy Mary Creagh confirmed today (24 October) that a new bill has been introduced to Parliament to ban the sale of single-use e-cigarettes from 1 June 2025.

 

The UK government has introduced legislation to ban the sale of remaining stocks by businesses by 1 June 2025, subject to parliamentary approval. Businesses will need to prepare for the ban to take effect. The UK Cabinet Office and local authorities are working closely together to set a consistent date.

 

Between 2012 and 2023, the use of e-cigarettes in England is expected to increase by over 400%, with 9.1% of the UK population currently buying and using these products.

 

Minister for the Circular Economy Mary Creagh said: "Single-use e-cigarettes are extremely wasteful and have caused concern in our towns and cities."

 

"That's why we need to ban single-use e-cigarettes to end the culture of waste in this country," she said. "This is the first step towards a circular economy, where we will extend the use of resources, reduce waste, accelerate progress towards net zero emissions and create thousands of job opportunities across the country."

 

Minister for Public Health and Prevention Andrew Gwynne added: "It is worrying that a quarter of 11-15 year olds used e-cigarettes last year, with disposable e-cigarettes being the choice of most children. Banning disposable e-cigarettes will not only help protect the environment, it will also reduce the appeal of e-cigarettes to children and prevent vulnerable young people from being influenced. The Government will also implement the Tobacco and Electronic Cigarettes Act, the most important public health measure for generations, to protect young people from the effects of nicotine and pave the way for a smoke-free Britain."

 

Green Alliance's Head of Resources, Libby Peake, said: "single-use e-cigarettes are the last thing our children and the planet need, and the unchecked growth of the market for them has gone on for far too long. Each one is a waste of vital resources needed for more sustainable economic development, such as the lithium used in electric vehicle batteries. When littered, the nicotine, plastics and batteries they contain are extremely harmful. Even if thrown away, their batteries can catch fire. Government bans on these harmful devices are a welcome step towards reducing waste in the economy."

 

"The emergence of single-use e-cigarettes, possibly the first mainstream disposable electronic device, is polluting our streets and reflects the continued evolution of the tobacco industry. The UK government's plan to ban these disposable products by 2025 is a popular and important step. The ban not only aims to reduce the number of discarded e-cigarettes, but also challenges the wider trend of disposable technology, which is contributing to a worrying increase in electronic waste, accompanied by fire hazards and the use of scarce materials. From a health perspective, I also welcome this ban and believe it is essential in breaking the control of e-cigarettes over young people and challenging the throwaway culture that threatens to choke our planet," said climate campaigner and environmental scientist, Less Waste Laura.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
The FDA has authorized four additional on! nicotine pouches, bringing the U.S. total to 30. The decision marks another outcome of the agency’s nicotine pouch review pilot, whose communication and review practices are now being applied more broadly across the category. It also extends Helix’s authorized portfolio from on! PLUS to the earlier on! line. Yet all FDA-authorized nicotine pouches still come from subsidiaries of PMI or Altria, underscoring how concentrated U.S. regulatory access remains.
Aug.05
UK HMRC Urges Public to Report Suspicious Vape Shops in Crackdown on Tax Fraud, Money Laundering and Illicit Tobacco Sales
UK HMRC Urges Public to Report Suspicious Vape Shops in Crackdown on Tax Fraud, Money Laundering and Illicit Tobacco Sales
HM Revenue & Customs is urging members of the public to report vape shops, barber shops and other high-street businesses suspected of tax fraud, money laundering or other illegal activity, with informants not required to provide personal details. HMRC plans more than 30,000 interventions in 2026-27 targeting tax fraud, organised crime and illicit activity, including the sale of illegal vapes and tobacco. The push forms part of a broader UK effort to tackle organised crime on high streets, backed by a £30 million government enforcement programme.
Regulations
Aug.17 by 2Firsts Perspectives
Philip Morris Romania Executive on Smoke-Free Strategy: How IQOS Spaces Are Moving Beyond Retail to Consumer Connection
Philip Morris Romania Executive on Smoke-Free Strategy: How IQOS Spaces Are Moving Beyond Retail to Consumer Connection
In an interview with Romanian marketing publication IQads, Marek Gębski, Director of Smoke-Free Products at Philip Morris Romania, said IQOS experience spaces are evolving from traditional retail locations into platforms for consumer engagement and brand connection. Through locations such as IQOS Boutique Victoriei, PMI aims to use design, culture and consumer experiences to strengthen communication with adult consumers about smoke-free products. The interview highlights how tobacco companies are expanding smoke-free strategies beyond products toward experiential marketing and consumer relationships.
Aug.11
UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
The UK Insolvency Service said YSK Enterprises imported large quantities of vapes from China in 2023, with a shipment addressed to the company declared as medical nebulizers before Border Force found 352,688 vaping products. HMRC calculated nearly £15 million ($20.3 million) in unpaid VAT and customs duty, alongside about £437,000 in corporation tax. Two directors were disqualified for nine years. The case predates the UK's Vaping Products Duty, which will introduce vape-specific excise and duty-stamp requirements from October 2026.
Regulations
Sep.11
As FDA Reshapes PMTA Reviews and ENDS Enforcement Priorities, CTP Acting Director Bret Koplow to Keynote NATO Event for a Retail Network of 66,000-Plus Stores
As FDA Reshapes PMTA Reviews and ENDS Enforcement Priorities, CTP Acting Director Bret Koplow to Keynote NATO Event for a Retail Network of 66,000-Plus Stores
Bret Koplow, acting director of the U.S. Food and Drug Administration's Center for Tobacco Products, will deliver a keynote and participate in a fireside chat at the National Association of Tobacco Outlets' Sept. 29-30 conference in Washington. His appearance comes months after the FDA moved to accelerate PMTA reviews and introduced a more differentiated enforcement policy for certain unauthorized ENDS and oral nicotine pouch products. The agency also plans a public list identifying manufacturers and products it does not currently intend to prioritize for enforcement under the May guidance. NATO says its membership includes more than 66,000 retail stores, making product-status transparency and enforcement boundaries directly relevant to the retail sector.
Aug.14
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA has published a Special Communication offering systematic recommendations for U.S.-based clinicians on the use of nicotine e-cigarettes in adult smoking cessation. Developed by the Harm Reduction Workgroup of the Society for Research on Nicotine and Tobacco’s Treatment Research Network, the paper recommends including e-cigarettes alongside FDA-approved cessation medications in risk-benefit discussions. It cites high-certainty evidence that nicotine e-cigarettes achieve higher quit rates than nicotine replacement therapy and evidence suggesting efficacy comparable to highly effective medications such as varenicline and cytisine. For adults who choose vaping to quit, the authors recommend FDA-authorized products, sufficient nicotine delivery and a rapid, complete transition away from cigarettes rather than prolonged dual use.
Aug.13